Key Events This Week
Mar 30: New 52-week low (Rs.37.49)
Apr 01: Upper circuit hit with 19.98% gain (Rs.44.98)
Apr 02: Continued strong rally to Rs.53.69 (+19.36%)
Apr 03: No trading data available
May 06
BSE+NSE Vol: 2.62 lacs

At Rs 56.97, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Brooks Laboratories Ltd locked at its upper circuit of 4.94% on 6 May 2026, with buyers queuing and no sellers willing to part with shares.
Read full news article
At Rs 58.77, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Brooks Laboratories Ltd locked at its upper circuit of 4.98% on 4 May 2026, with buyers queuing and no sellers willing to part with shares.
Read full news article
At Rs 58.7, sellers were still queuing — but there were no buyers willing to take the other side. Brooks Laboratories Ltd locked at its lower circuit of 5% on 29 Apr 2026, with unfilled sell orders and a frozen price, signalling persistent selling pressure in a micro-cap stock with limited liquidity.
Read full news article
Brooks Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
At Rs 64.36, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Brooks Laboratories Ltd locked at its upper circuit of 4.99% on 23 Apr 2026, with buyers queuing and no sellers willing to part with shares.
Read full news article
Brooks Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 February 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 17 April 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.
Read full news article
At Rs 64.05, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Brooks Laboratories Ltd locked at its upper circuit of 19.99% on 6 Apr 2026, with buyers queuing and no sellers willing to part with shares.
Read full news article
Brooks Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 April 2026, providing investors with an up-to-date view of its fundamentals, returns, and technical outlook.
Read full news articleFormat of Initial Disclosure to be made by an entity identified as a Large Corporate.
| Sr. No. | Particulars | Details |
| 1 | Name of Company | Brooks Laboratories Ltd |
| 2 | CIN NO. | L24232HP2002PLC000267 |
| 3 | Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) | 1.19 |
| 4 | Highest Credit Rating during the previous FY | CAREBBSTABLECAREA4 |
| 4a | Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4) | CARE RATINGS LIMITED |
| 5 | Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework | BSE |
Certificate under Regulation 74(5) of SEBI(DP) Regulation 2018 for quarter ended 31st March 2026.
Reply to clarification sought vide email dated 1st April 2026 with reference to Price Movement.
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
Brooks Laboratories Ltd has announced 1:16 rights issue, ex-date: 28 Jul 23